MAPK3 and neoplasm: As reported above, β-ARs trigger such signalling pathways to promote tumour proliferation; hence, we determined the effects of drugs on the expression and activation status of Erk1/2 and Akt to find a correlation with the tumour cell response to doxorubicin (Fig. 5A, Figure S3).